loadpatents
name:-0.080654144287109
name:-0.043462991714478
name:-0.013911008834839
Magnani; John L. Patent Filings

Magnani; John L.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Magnani; John L..The latest application filed is for "process for preparing an e-selectin inhibitor intermediate".

Company Profile
13.48.70
  • Magnani; John L. - Gaithersburg MD
  • Magnani; John L - Gaithersburg MD
  • Magnani; John L. - Frederick MD
  • Magnani; John L. - Rockville MD
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Process For Preparing An E-selectin Inhibitor Intermediate
App 20220289784 - Flanner; Henry H. ;   et al.
2022-09-15
Combination of T-cell checkpoint inhibitors with inhibitors of e-selectin or CXCR4, or with heterobifunctional inhibitors of both E-selectin and CXCR4
Grant 11,433,086 - Magnani , et al. September 6, 2
2022-09-06
Methods For Use Of Gene Expression As An Indicator Of E-selectin Inhibitor Efficacy And Clinical Outcome For Multiple Tumor Types
App 20220265691 - MAGNANI; John L. ;   et al.
2022-08-25
Use Of E-selectin Antagonists To Enhance The Survival Of Reconstituted, Bone Marrow-depleted Hosts
App 20220265693 - MAGNANI; John L. ;   et al.
2022-08-25
Use Of Highly Potent Multimeric E-selectin Antagonists For Treating Sickle Cell Disease
App 20220257775 - MAGNANI; John L. ;   et al.
2022-08-18
Multimeric Pan-selectin Antagonists
App 20220220144 - MAGNANI; John L. ;   et al.
2022-07-14
Galactopyranosyl-cyclohexyl Derivatives As E-selectin Antagonists
App 20220175808 - MAGNANI; John L. ;   et al.
2022-06-09
E-selectin antagonist compounds, compositions, and methods of use
Grant 11,332,491 - Magnani , et al. May 17, 2
2022-05-17
Methods for the treatment and/or prevention of cardiovascular disease by inhibition of E-selectin
Grant 11,291,678 - Magnani , et al. April 5, 2
2022-04-05
Heterobifunctional Inhibitors Of E-selectin And Galectin-3
App 20220089633 - MAGNANI; John L. ;   et al.
2022-03-24
Galectin-3 Inhibiting C-glycosides
App 20220073555 - MAGNANI; John L. ;   et al.
2022-03-10
Galactopyranosyl-cyclohexyl derivauves as E-selectin antagonists
Grant 11,197,877 - Magnani , et al. December 14, 2
2021-12-14
Highly Potent Multimeric E-selectin Antagonists
App 20210323990 - MAGNANI; John L. ;   et al.
2021-10-21
Highly potent multimeric e-selectin antagonists
Grant 11,072,625 - Magnani , et al. July 27, 2
2021-07-27
Glycomimetic inhibitors of PA-IL and PA-IIL lectins
Grant 11,045,485 - Magnani , et al. June 29, 2
2021-06-29
Methods Of Mobilizing Marrow Infiltrating Lymphocytes And Uses Thereof
App 20210177878 - MAGNANI; John L. ;   et al.
2021-06-17
E-selectin Antagonist Compounds, Compositions, And Methods Of Use
App 20210017215 - MAGNANI; John L. ;   et al.
2021-01-21
Heterobifunctional Inhibitors Of E-selectin And Galectin-3
App 20200399301 - MAGNANI; John L. ;   et al.
2020-12-24
Haloalkyl Fucose-containing Selectin Antagonists
App 20200316100 - ERNST; Beat ;   et al.
2020-10-08
E-selectin antagonist compounds, compositions, and methods of use
Grant 10,766,916 - Magnani , et al. Sep
2020-09-08
E-selectin Antagonist Compounds, Compositions, And Methods Of Use
App 20200157134 - MAGNANI; John L. ;   et al.
2020-05-21
Galactopyranosyl-cyclohexyl Derivatives As E-selectin Antagonists
App 20200129536 - MAGNANI; John L ;   et al.
2020-04-30
E-selectin antagonist compounds, compositions, and methods of use
Grant 10,526,361 - Magnani , et al. J
2020-01-07
Heterobifunctional inhibitors of E-selectins and CXCR4 chemokine receptors
Grant 10,519,181 - Magnani , et al. Dec
2019-12-31
Highly Potent Multimeric E-selectin Antagonists
App 20190233458 - MAGNANI; John L. ;   et al.
2019-08-01
Combination Of T-cell Checkpoint Inhibitors With Inhibitors Of E-selectin Or Cxcr4, Or With Heterobifunctional Inhibitors Of Bot
App 20190201429 - MAGNANI; John L ;   et al.
2019-07-04
Methods For The Treatment And/or Prevention Of Cardiovescular Disease By Inhibition Of E-selectin
App 20190060339 - MAGNANI; John L. ;   et al.
2019-02-28
Glycomimetic Inhibitors Of Pa-il And Pa-iil Lectins
App 20190060338 - MAGNANI; John L. ;   et al.
2019-02-28
Antibodies For Targeting Cancer Stem Cells And Treating Aggressive Cancers
App 20180318325 - MAGNANI; John L.
2018-11-08
Methods And Compositions For The Production Of Monoclonal Antibodies, Hematopoietic Stem Cells, And Methods Of Using The Same
App 20180320136 - MAGNANI; John L.
2018-11-08
Methods For The Mobilization And Use Of T-cells With Enhanced Reconstitution Potential And Life-span
App 20180228871 - KING; Rachel K. ;   et al.
2018-08-16
E-selectin Antagonist Compounds, Compositions, And Methods Of Use
App 20180066006 - MAGNANI; John L. ;   et al.
2018-03-08
Compounds, compositions and methods using E-selectin antagonists for mobilization of hematopoietic cells
Grant 9,867,841 - Magnani January 16, 2
2018-01-16
Heterobifunctional Inhibitors Of E-selectins And Cxcr4 Chemokine Receptors
App 20170305951 - MAGNANI; John L ;   et al.
2017-10-26
E-selectin antagonist compounds, compositions, and methods of use
Grant 9,796,745 - Magnani , et al. October 24, 2
2017-10-24
Methods And Compositions For Treating And/or Preventing Mucositis
App 20170296566 - MAGNANI; John L. ;   et al.
2017-10-19
Pan-selectin inhibitor with enhanced pharmacokinetic activity
Grant 9,534,009 - Magnani January 3, 2
2017-01-03
Heterobifunctional Pan-selectin Inhibitors
App 20160361332 - Magnani; John L. ;   et al.
2016-12-15
E-selectin Inhibition Works In Combination With Low-molecular Weight Heparin To Decrease Venous Thrombosis And Bleeding Risk
App 20160331775 - MYERS, JR.; DANIEL D. ;   et al.
2016-11-17
E-Selectin Antagonists Modified By Macrocycle Formation to the Galactose
App 20160333043 - MAGNANI; John L. ;   et al.
2016-11-17
Glycomimetic Compounds And Methods To Inhibit Infection By Hiv
App 20160289257 - Magnani; John L. ;   et al.
2016-10-06
Methods And Compositions For Treating And/or Preventing Mucositis
App 20160243145 - MAGNANI; John L. ;   et al.
2016-08-25
Compounds, Compositions and Methods Using E-Selectin Antagonists for Mobilization of Hematopoietic Cells
App 20160184339 - MAGNANI; John L.
2016-06-30
E-selectin Antagonist Compounds, Compositions, And Methods Of Use
App 20160145290 - MAGNANI; John L. ;   et al.
2016-05-26
E-selectin Antagonist Compounds And Methods Of Use
App 20150284420 - Magnani; John L. ;   et al.
2015-10-08
E-selectin antagonist compounds, compositions, and methods of use
Grant 9,109,002 - Magnani , et al. August 18, 2
2015-08-18
E-selectin Antagonist Compounds, Compositions, And Methods Of Use
App 20150110808 - Magnani; John L. ;   et al.
2015-04-23
Pan-selectin Inhibitor With Enhanced Pharmacokinetic Activity
App 20150051164 - Magnani; John L.
2015-02-19
Pan-selectin inhibitor with enhanced pharmacokinetic activity
Grant 8,895,510 - Magnani November 25, 2
2014-11-25
Heterobifunctional Pan-selectin Inhibitors
App 20140178303 - Magnani; John L. ;   et al.
2014-06-26
Glycomimetic Compounds And Methods To Inhibit Infection By Hiv
App 20140073594 - Magnani; John L. ;   et al.
2014-03-13
Heterobifunctional pan-selectin inhibitors
Grant RE44,778 - Magnani , et al. February 25, 2
2014-02-25
Heterobifunctional pan-selectin inhibitors
Grant 8,633,303 - Magnani , et al. January 21, 2
2014-01-21
Anti-epileptogenic Agents
App 20130261070 - Magnani; John L. ;   et al.
2013-10-03
Compounds and methods for inhibiting selectin-mediated function
Grant 8,530,448 - Magnani , et al. September 10, 2
2013-09-10
Treatment of cancers of the blood using selected glycomimetic compounds
Grant 8,518,896 - Magnani , et al. August 27, 2
2013-08-27
Heterobifunctional Inhibitors Of E-selectins And Cxcr4 Chemokine Receptors
App 20130184229 - MAGNANI; John L. ;   et al.
2013-07-18
Heterobifunctional inhibitors of E-selectins and CXCR4 chemokine receptors
Grant 8,410,066 - Magnani , et al. April 2, 2
2013-04-02
Compounds and methods for treatment of sickle cell or complications associated therewith
Grant 8,361,975 - Magnani January 29, 2
2013-01-29
Glycomimetic Inhibitors Of The Pa-il Lectin, Pa-iil Lectin Or Both The Lectins From Pseudomonas
App 20120329755 - Magnani; John L. ;   et al.
2012-12-27
Glycomimetic inhibitors of the PA-IL lectin, PA-IIL lectin or both the lectins from pseudomonas
Grant 8,258,290 - Magnani , et al. September 4, 2
2012-09-04
Methods Of Use Of Glycomimetics With Replacements For Hexoses And N-acetyl Hexosamines
App 20120202762 - MAGNANI; John L.
2012-08-09
Compounds And Methods For Treatment Of Sickle Cell Disease Or Complications Associated Therewith
App 20120015898 - MAGNANI; John L.
2012-01-19
Heterobifunctional Pan-selectin Inhibitors
App 20120004190 - MAGNANI; John L. ;   et al.
2012-01-05
Glycomimetic Replacements For Hexoses And N-acetyl Hexosamines
App 20110257380 - ERNST; Beat ;   et al.
2011-10-20
Compounds and methods for treatment of sickle cell disease or complications associated therewith
Grant 8,039,442 - Magnani October 18, 2
2011-10-18
Glycomimetic Compounds And Methods To Inhibit Infection By Hiv
App 20110251148 - MAGNANI; John L. ;   et al.
2011-10-13
Methods of use of glycomimetics with replacements for hexoses and n-acetyl hexosamines
Grant 8,026,222 - Magnani September 27, 2
2011-09-27
Heterobifunctional pan-selectin inhibitors
Grant 7,989,601 - Magnani , et al. August 2, 2
2011-08-02
Glycomimetic replacements for hexoses and N-acetyl hexosamines
Grant 7,964,569 - Ernst , et al. June 21, 2
2011-06-21
Detection And Treatment Of Prostate Cancer
App 20110027180 - MAGNANI; John L.
2011-02-03
Heterobifunctional Inhibitors Of E-selectins And Cxcr4 Chemokine Receptors
App 20100279965 - Magnani; John L. ;   et al.
2010-11-04
Compounds And Methods For Inhibiting Selectin-mediated Function
App 20100279958 - MAGNANI; John L. ;   et al.
2010-11-04
Heterobifunctional Pan-selectin Inhibitors
App 20100204170 - MAGNANI; John L. ;   et al.
2010-08-12
Compounds and methods for inhibiting selectin-mediated function
Grant 7,741,312 - Magnani , et al. June 22, 2
2010-06-22
Heterobifunctional pan-selectin inhibitors
Grant 7,728,117 - Magnani , et al. June 1, 2
2010-06-01
Detection and treatment of prostate cancer
Grant 7,727,735 - Magnani June 1, 2
2010-06-01
Glycomimetic Inhibitors Of The Pa-il Lectin, Pa-iil Lectin Or Both The Lectins From Pseudomonas
App 20100041626 - Magnani; John L. ;   et al.
2010-02-18
Treatment Of Cancers Of The Blood Using Selected Glycomimetic Compounds
App 20090312278 - MAGNANI; John L. ;   et al.
2009-12-17
Pan-selectin Inhibitor With Enhanced Pharmacokinetic Activity
App 20090253646 - MAGNANI; John L.
2009-10-08
Glycomimetic Inhibitors Of Siglec-8
App 20090175792 - Magnani; John L. ;   et al.
2009-07-09
Galactosides And Thiodigalactosides As Inhibitors Of Pa-il Lectin From Pseudomonas
App 20090176717 - Magnani; John L.
2009-07-09
Glycomimetric inhibitors of the PA-IL lectin, PA-IIL lectin or both the lectins from Pseudomonas
Grant 7,517,980 - Magnani , et al. April 14, 2
2009-04-14
Heterobifunctional compounds for selectin inhibition
App 20090036386 - Magnani; John L. ;   et al.
2009-02-05
Compounds and methods for treatment of sickle cell disease or complications associated therewith
App 20090023679 - Magnani; John L.
2009-01-22
Methods of use of glycomimetics with replacements for hexoses and n-acetyl hexosamines
App 20080200406 - Magnani; John L.
2008-08-21
Glycomimetic replacements for hexoses and N-acetyl hexosamines
App 20080161546 - Ernst; Beat ;   et al.
2008-07-03
Specific antagonist for both E- and P-selectins
Grant 7,361,644 - Magnani , et al. April 22, 2
2008-04-22
Heterobifunctional pan-selectin inhibitors
App 20070054870 - Magnani; John L. ;   et al.
2007-03-08
Detection and treatment of prostate cancer
App 20070048809 - Magnani; John L.
2007-03-01
Glycomimetic inhibitors of the PA-IL lectin, PA-IIL lectin or both the lectins from pseudomonas
App 20070037775 - Magnani; John L. ;   et al.
2007-02-15
Detection and treatment of prostate cancer
Grant 7,135,301 - Magnani November 14, 2
2006-11-14
Compounds and methods for inhibiting selectin-mediated function
App 20060194745 - Magnani; John L. ;   et al.
2006-08-31
Compounds and methods for inhibiting selectin-mediated function
Grant 7,060,685 - Magnani , et al. June 13, 2
2006-06-13
Glycomimetic antagonists for both E-and P-selectins
App 20050187171 - Magnani, John L. ;   et al.
2005-08-25
Specific antagonist for both E- and P-selectins
App 20050164982 - Magnani, John L. ;   et al.
2005-07-28
Compounds and methods for inhibiting selectin-mediated function
App 20040254145 - Magnani, John L. ;   et al.
2004-12-16
Compositions and methods for diagnosis and therapy of medical conditions involving infection with pseudomonas bacteria
App 20040219158 - Magnani, John L.
2004-11-04
Compositions and methods for diagnosis and therapy of medical conditions involving angiogenesis
App 20040096396 - Magnani, John L. ;   et al.
2004-05-20
Methods and compositions for the inhibition of cancer metastasis mediated by endothelial adhesion molecules
App 20030133937 - Magnani, John L. ;   et al.
2003-07-17
Detection and treatment of prostate cancer
App 20030096327 - Magnani, John L.
2003-05-22
Methods and compositions for the inhibition of cancer metastasis mediated by endothelial adhesion molecules
Grant 6,465,434 - Magnani , et al. October 15, 2
2002-10-15
Leukocyte homing modulation
Grant 6,387,884 - Magnani , et al. May 14, 2
2002-05-14
Pharmaceutical compositions for treatment of EGF receptor associated cancers
Grant 6,281,202 - Magnani , et al. August 28, 2
2001-08-28
Methods for the inhibition of cancer metastasis mediated by endothelial adhesion molecules
Grant 6,121,233 - Magnani , et al. September 19, 2
2000-09-19
Methods for treatment of EGF receptor associated cancers
Grant 6,008,203 - Magnani , et al. December 28, 1
1999-12-28
Methods of screening for a candidate compound able to bind to CD34.sup.+ cells
Grant 5,965,457 - Magnani October 12, 1
1999-10-12
Company Registrations
SEC0001589713Magnani John L.

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed